Method and compositions for the treatment and detection of endothelin-1 related kidney diseases
AssigneeMorehouse School of Medicine
InventorsGale W. Newman, Barbara A. Jacob-Mungin, Chamberlain Obialo
Life of this patent
Estimating the term…
Abstract
The present application relates to methods of treating HIV-associated nephropathy (HIVAN) and/or focal segmental glomerulosclerosis (FSGS) using endothelin-1 (ET-1) antagonists. The application further relates to a composition for the treatment of HIVAN and/or FSGS. A kit for detecting the presence of ET-1 or ET-1-associated biomarker in a biological sample is also disclosed.
Claims20
A method of treating HIV-associated nephropathy (HIVAN) or focal segmental glomerulosclerosis (FSGS), comprising administering to a mammalian subject an effective amount of a composition comprising an ET-1 antagonist, wherein the subject has an increased level of ET-1 compared to a control subject.
A method for diagnosis of Nephropathy in a subject, comprising:
- comparing a level of an ET-1-associated biomarker in a biological sample obtained from the subject to a threshold level;
- and
- making a diagnosis based a result from the comparing step.
A composition for the treatment of HIVAN or FSGS, said composition comprising an ET-1 antagonist and a pharmaceutically acceptable carrier.
A kit for detecting the presence of an ET-1-associated biomarker in a biological sample, wherein said kit comprises one or more reagents suitable for measuring the ET-1-associated biomarker in the biological sample;
- and instructions for using said kit to detect said ET-1-associated biomarker, wherein the biological sample is blood, plasma, urine, saliva or tissue.
Dependencies are inferred from the claim text.